EA200600216A3 - Method of protection immune state in an organism suffering from diabetes mellitus - Google Patents

Method of protection immune state in an organism suffering from diabetes mellitus

Info

Publication number
EA200600216A3
EA200600216A3 EA200600216A EA200600216A EA200600216A3 EA 200600216 A3 EA200600216 A3 EA 200600216A3 EA 200600216 A EA200600216 A EA 200600216A EA 200600216 A EA200600216 A EA 200600216A EA 200600216 A3 EA200600216 A3 EA 200600216A3
Authority
EA
Eurasian Patent Office
Prior art keywords
diabetes mellitus
immune state
organism suffering
protection immune
protection
Prior art date
Application number
EA200600216A
Other languages
Russian (ru)
Other versions
EA008925B1 (en
EA200600216A2 (en
Inventor
Александр Павлович Францев
Ирина Александровна Францева
Original Assignee
Товарищество С Ограниченной Ответственностью "Реал Мед Компани"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Товарищество С Ограниченной Ответственностью "Реал Мед Компани" filed Critical Товарищество С Ограниченной Ответственностью "Реал Мед Компани"
Publication of EA200600216A2 publication Critical patent/EA200600216A2/en
Publication of EA200600216A3 publication Critical patent/EA200600216A3/en
Publication of EA008925B1 publication Critical patent/EA008925B1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Изобретение относится к медицине, в частности к эндокринологии и иммунологии, и касается коррекции патологического иммунного процесса при сахарном диабете типа II. Повышение эффективности способа и сокращение сроков лечения достигается тем, что в способе коррекции иммунного состояния организма, включающем введение антиидиотипических антител, согласно изобретению используют антиидиотипические антитела к α-фетопротеину.The invention relates to medicine, in particular to endocrinology and immunology, and concerns the correction of the pathological immune process in diabetes mellitus type II. Improving the efficiency of the method and reducing the time of treatment is achieved by the fact that the method of correction of the immune state of the body, including the introduction of antiidiotypic antibodies, according to the invention uses antiidiotypic antibodies to α-fetoprotein.

EA200600216A 2004-12-14 2005-12-12 Method of protection immune state in an organism suffering from diabetes mellitus EA008925B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KZ20041770 2004-12-14

Publications (3)

Publication Number Publication Date
EA200600216A2 EA200600216A2 (en) 2006-08-25
EA200600216A3 true EA200600216A3 (en) 2006-10-27
EA008925B1 EA008925B1 (en) 2007-08-31

Family

ID=40848965

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200600216A EA008925B1 (en) 2004-12-14 2005-12-12 Method of protection immune state in an organism suffering from diabetes mellitus

Country Status (1)

Country Link
EA (1) EA008925B1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6887096A (en) * 1996-09-11 1998-04-02 Patrick T. Prendergast Immune direction therapy
US6696545B1 (en) * 1997-04-11 2004-02-24 Sangstat Medical Corporation Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation
CN1281978A (en) * 2000-07-13 2001-01-31 厦门大学 Anti-alpha-fetoprotein antibody labelled by fluorescein and its preparation method
RU2228198C1 (en) * 2002-08-21 2004-05-10 Полетаев Александр Борисович Method for adjusting pathological autoimmune process in the cases of diabetes mellitus

Also Published As

Publication number Publication date
EA008925B1 (en) 2007-08-31
EA200600216A2 (en) 2006-08-25

Similar Documents

Publication Publication Date Title
EA200800812A1 (en) Antibody Anti-CD3 Compositions
EA200970262A1 (en) COMPOSITIONS AND METHODS RELATING TO ANTIBODIES TO GLUCAGON RECEPTORS
EA200801427A1 (en) ANTIBODY MOLECULES WITH SPECIFIC ACTIVITY WITH RESPECT TO HUMAN INTERLEUKIN-6 (IL-6)
EA201070553A1 (en) ANTIBODIES TO HEPCIDIN AND VARIANTS OF THEIR APPLICATION
EA200800763A1 (en) THERAPEUTIC COMPOSITIONS CONTAINING HYALURONIC ACID AND THERAPEUTIC ANTIBODIES AND ALSO WAYS OF TREATMENT
GB2433936B (en) Therapeutic peptides
WO2004047728A3 (en) Compositions and methods for the treatment of immune related diseases
WO2005019258A3 (en) Compositions and methods for the treatment of immune related diseases
EA200701092A1 (en) Interleukin-21 antigen epitopes, associated antibodies and their use in medicine.
WO2003100033A3 (en) ANTI-αvβ6 ANTIBODIES
SG170749A1 (en) Anti-ilt7 antibody
EP2107071A3 (en) Anti-EpCAM immunoglobulins
PL1648513T3 (en) Use of adcc-optimized antibodies for treating patients answering weakly to antibody treatment.
TW200635946A (en) Binding proteins specific for human matriptase
HK1108568A1 (en) Method of preventive treatment of allergy by mucosal administration of an allergy vaccine
RU2008152769A (en) HUMANIZED ANTIBODY AGAINST HUMAN OSTEOPONTIN
EA200801310A1 (en) PHARMACEUTICAL PREPARATIONS AND THEIR APPLICATION IN THE TREATMENT OF SEXUAL DYSFUNCTION IN WOMEN
PE20050962A1 (en) FULLY HUMAN ANTIBODIES VS HUMAN 4-1BB
WO2004024072A3 (en) Novel compositions and methods for the treatment of immune related diseases
EA200501078A1 (en) Phenoxyethers of Amino Acid
EA200600216A2 (en) Method of protection immune state in an organism suffering from diabetes mellitus
EA200700425A1 (en) GLYCOPROTEIN CELLULAR SURFACE
WO2007012671A3 (en) Method for genetic immunization by electrotransfer against a toxin and antiserum obtainable by said method
WO2003097082A3 (en) Treatment of crohn's disease or psoriasis using anti-inteferon gamma antibodies
EA200600218A3 (en) Method of correction an organism immune state in anemia

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): KZ

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU